Review: taking Zantac 150 and Compazine together


Summary

Drug interactions are reported among people who take Zantac 150 and Compazine together. This review analyzes the effectiveness and drug interactions between Zantac 150 and Compazine. It is created by eHealthMe based on reports of 283 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Zantac 150 and Compazine >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Zantac 150

Zantac 150 has active ingredients of ranitidine hydrochloride. It is often used in indigestion. (latest outcomes from Zantac 150 4,130 users)

Compazine

Compazine has active ingredients of prochlorperazine maleate. It is often used in nausea. (latest outcomes from Compazine 753 users)

On Aug, 23, 2016

283 people who take Zantac 150, Compazine are studied.


Number of reports submitted per year:

Zantac 150 and Compazine drug interactions.

Drug effectiveness over time:

Zantac 150:
  • < 1 month: 0.0% - (0 of 1 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)
Compazine:
  • < 1 month: 0.0% - (0 of 1 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Zantac 150:
  • female: 0.0% - (0 of 0 people)
  • male: 0.0% - (0 of 1 people)
Compazine:
  • female: 0.0% - (0 of 0 people)
  • male: 0.0% - (0 of 1 people)

Drug effectiveness by age:

Zantac 150:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 0.0% - (0 of 0 people)
  • 60+: 0.0% - (0 of 1 people)
Compazine:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 0.0% - (0 of 0 people)
  • 60+: 0.0% - (0 of 1 people)

Most common drug interactions over time *:

< 1 month:
  • anaemia
  • nausea
  • atrial tachycardia
  • pyrexia
  • pneumonia
  • vomiting
  • bacteriuria
  • sepsis
  • hepatic failure
  • pain
1 - 6 months:
  • hepatic function abnormal
  • interstitial lung disease
  • metastases to liver
  • platelet count decreased
  • blood albumin decreased
  • pneumocystis jiroveci pneumonia
  • neutrophil count decreased
  • white blood cell count decreased
  • dizziness
  • fall
1 - 2 years:
  • jaw disorder
  • osteonecrosis
  • tooth extraction
2 - 5 years:
  • myelodysplastic syndrome
5 - 10 years:
  • pneumonia
not specified:
  • vomiting
  • nausea
  • dehydration
  • dyspnoea
  • diarrhoea
  • pyrexia
  • anaemia
  • fatigue
  • pain
  • headache

Most common drug interactions by gender *:

female:
  • pyrexia
  • vomiting
  • nausea
  • dehydration
  • anaemia
  • fatigue
  • dyspnoea
  • pneumonia
  • headache
  • asthenia
male:
  • diarrhoea
  • nausea
  • vomiting
  • anaemia
  • dyspnoea
  • constipation
  • pain
  • neuropathy peripheral
  • cough
  • insomnia

Most common drug interactions by age *:

0-1:
  • hypophagia
  • weight gain poor
2-9:
  • anaphylactic reaction
  • anaphylactoid reaction
  • cough
  • hypersensitivity
  • hypertension
  • infusion related reaction
10-19:
  • headache
  • abdominal pain
  • abdominal pain upper
  • alveolar osteitis
  • amnesia
  • anhedonia
  • anxiety
  • arthralgia
  • arthritis
  • asthenia
20-29:
  • atrial tachycardia
  • chills
  • headache
  • hypotension
  • influenza
  • influenza like illness
  • nasopharyngitis
  • nausea
  • ocular hyperaemia
  • pain
30-39:
  • anaemia
  • vomiting
  • nausea
  • dizziness
  • fatigue
  • pyrexia
  • abdominal pain
  • anxiety
  • blister
  • decreased appetite
40-49:
  • nausea
  • pyrexia
  • diarrhoea
  • stomatitis
  • cough
  • dehydration
  • dyspnoea
  • pancytopenia
  • vomiting
  • anaemia
50-59:
  • feeling cold
  • nausea
  • renal failure acute
  • vomiting
  • diarrhoea
  • dyspnoea
  • fatigue
  • cyanosis
  • diabetic gastropathy
  • malaise
60+:
  • vomiting
  • pneumonia
  • fatigue
  • pyrexia
  • dehydration
  • asthenia
  • decreased appetite
  • anaemia
  • paraesthesia
  • renal failure acute

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Zantac 150 and Compazine?

Can you answer these questions?

More questions for: Zantac 150, Compazine

You may be interested in these reviews

More reviews for: Zantac 150, Compazine

On eHealthMe, Zantac 150 (ranitidine hydrochloride) is often used to treat indigestion. Compazine (prochlorperazine maleate) is often used to treat nausea. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.